Donglai Yang

age ~65

from Milford, MA

Get Report
Also known as:
  • Yang Donglai
Phone and address:
7 Karen Ln, Milford, MA 01757
Related to:
Connected to:

Donglai Yang Phones & Addresses

  • 7 Karen Ln, Milford, MA 01757
  • Annandale, NJ
  • 2501 Soldiers Home Rd, West Lafayette, IN 47906 • 7654648269
  • 120 Knox Dr, West Lafayette, IN 47906
  • Malden, MA
  • Haverhill, MA
  • Waltham, MA
  • W Lafayette, IN

Work

  • Position:
    Service Occupations

Vehicle Records

  • Donglai Yang

    view source
  • Address:
    7 Karen Ln, Milford, MA 01757
  • Phone:
    7654648269
  • VIN:
    JH4CU26699C033047
  • Make:
    ACURA
  • Model:
    TSX
  • Year:
    2009

Resumes

Donglai Yang Photo 1

Principal Investigator

view source
Location:
New York, NY
Industry:
Pharmaceuticals
Work:
sanofi-aventis - NJ since 2006
Principal Investigator
SSCI - A Division of Aptuit 2003 - 2006
Research Investigator
ArQule 2001 - 2003
Staff Investigator
Eli Lilly and Company 1999 - 2001
Research Chemist
School of Phamacy, Purdue 1998 - 1999
Research Associate
Skills:
Analytical Chemistry
Drug Discovery
Medicinal Chemistry
Formulation
Hplc
Drug Development
Pharmaceutical Industry
Drug Design
Glp
Chromatography
Lc Ms
Purification
Lifesciences
Donglai Yang Photo 2

Donglai Yang

view source

Us Patents

  • Forms Of Rifaximin And Uses Thereof

    view source
  • US Patent:
    8486956, Jul 16, 2013
  • Filed:
    Feb 19, 2010
  • Appl. No.:
    12/708836
  • Inventors:
    Karen S. Gushurst - West Lafayette IN, US
    Donglai Yang - Annandale NJ, US
    Petinka Vlahova - West Lafayette IN, US
    Jeffrey S. Stults - Lafayette IN, US
  • Assignee:
    Salix Pharmaceuticals, Ltd - Raleigh NC
  • International Classification:
    C07D 498/22
    A61K 31/395
    A61P 31/04
  • US Classification:
    514279, 540456
  • Abstract:
    The present invention relates to Rifaximin polymorphic forms, to their use in medicinal preparations and to therapeutic methods using them.

  • Forms Of Rifaximin And Uses Thereof

    view source
  • US Patent:
    8569326, Oct 29, 2013
  • Filed:
    Aug 16, 2012
  • Appl. No.:
    13/587537
  • Inventors:
    Karen S. Gushurst - West Lafayette IN, US
    Donglai Yang - Annandale NJ, US
    Petinka Vlahova - West Lafayette IN, US
    Jeffrey S. Stults - Lafayette IN, US
  • Assignee:
    Salix Pharmaceuticals, Ltd. - Raleigh NC
  • International Classification:
    C07D 498/22
    A61K 31/395
  • US Classification:
    514279, 540456
  • Abstract:
    The present invention relates to Rifaximin polymorphic forms, to their use in medicinal preparations and to therapeutic methods using them.

  • Crystalline And Amorphous Forms Of Tiagabine

    view source
  • US Patent:
    20080051435, Feb 28, 2008
  • Filed:
    Aug 16, 2007
  • Appl. No.:
    11/893524
  • Inventors:
    Scott Childs - Atlanta GA, US
    Karen Gushurst - West Lafayette IN, US
    R. Haltiwanger - West Chester PA, US
    Robert McKean - Chester Springs PA, US
    Donglai Yang - West Lafayette IN, US
  • Assignee:
    Cephalon, Inc. - Frazer PA
  • International Classification:
    C07D 409/14
    A61K 31/4535
  • US Classification:
    514326000, 546212000
  • Abstract:
    The present invention provides 24 new forms of tiagabine, including 22 new crystalline forms of tiagabine and its salts, an amorphous form of tiagabine free base, and a cocrystal form of tiagabine hydrochloride with 2-furancarboxylic acid. The present invention further provides a process for preparing each of the new tiagabine forms. The present invention further provides a pharmaceutical composition containing at least one of the new tiagabine forms, and a process for the preparation thereof. The present invention further provides a method of treating a disease related to GABA uptake in a mammal, comprising the step of administering to the mammal a therapeutically effective amount of at least one of the new tiagabine forms.

  • Crystalline Forms Of Tiagabine Hydrochloride

    view source
  • US Patent:
    20080064727, Mar 13, 2008
  • Filed:
    Aug 16, 2007
  • Appl. No.:
    11/893618
  • Inventors:
    Scott Childs - Atlanta GA, US
    Leonard Chyall - Lafayette IN, US
    Karen Gushurst - West Lafayette IN, US
    R. Haltiwanger - West Chester PA, US
    Robert McKean - Chester Springs PA, US
    Donglai Yang - West Lafayette IN, US
  • Assignee:
    Cephalon, Inc. - Frazer PA
  • International Classification:
    A61K 31/496
    A61P 25/00
    C07D 409/14
  • US Classification:
    514326000, 546212000
  • Abstract:
    The present invention provides 16 new crystalline forms of tiagabine hydrochloride.

  • Forms Of Rifaximin And Uses Thereof

    view source
  • US Patent:
    20100239664, Sep 23, 2010
  • Filed:
    Feb 25, 2009
  • Appl. No.:
    12/393012
  • Inventors:
    Karen S. Gushurst - West Lafayette IN, US
    Donglai Yang - Annandale NJ, US
    Melanie Roe - Lafayette IN, US
    Nathan Schultheiss - Lafayette IN, US
    Petinka Vlahova - West Lafayette IN, US
    Jeffrey S. Stults - Lafayette IN, US
    Travis L. Houston - Lafayette IN, US
  • Assignee:
    SALIX PHARMACEUTICALS, LTD. - Morrisville NC
  • International Classification:
    A61K 9/48
    A61K 31/437
    A61K 9/36
    A61K 9/28
    C07D 498/22
    A61P 1/00
    A61P 1/12
  • US Classification:
    424456, 514279, 424479, 424474, 540457
  • Abstract:
    The present invention relates to Rifaximin polymorphic, salt, hydrate, and amorphous forms, to their use in medicinal preparations and to therapeutic methods using them.

  • Salts And Crystal Forms

    view source
  • US Patent:
    20110053997, Mar 3, 2011
  • Filed:
    Dec 5, 2008
  • Appl. No.:
    12/746239
  • Inventors:
    Alexander Beliaev - Mindelo, PT
    David Alexander Learmonth - Alfena, PT
    Melanie J. Roe - Lafayette IN, US
    Petinka Vlahova - West Lafayette IN, US
    Eric Hagen - Lafayette IN, US
    Valeriya Smolenskaya - Lafayette IN, US
    Donglai Yang - Annandale NJ, US
  • International Classification:
    A61K 31/4178
    C07D 405/04
    A61P 9/00
  • US Classification:
    514397, 5483114
  • Abstract:
    The present invention relates to novel salts of the compound (R)-5-(2-Aminoethyl)-1-(6,8-difluorochroman-3-yl)-1,3-dihydroimidazole-2-thione, polymorphs of the salts and methods of their preparation.

  • Forms Of Rifaximin And Uses Thereof

    view source
  • US Patent:
    20120076857, Mar 29, 2012
  • Filed:
    Sep 6, 2011
  • Appl. No.:
    13/226053
  • Inventors:
    Karen S. Gushurst - West Lafayette IN, US
    Donglai Yang - Annandale NJ, US
    Melanie Roe - Lafayette IN, US
    Nathan Schultheiss - Lafayette IN, US
    Petinka Vlahova - West Lafayette IN, US
    Jeffrey S. Stults - West Lafayette IN, US
    Travis L. Houston - Lafayette IN, US
  • Assignee:
    SALIX PHARMACEUTICALS, LTD. - Raleigh NC
  • International Classification:
    A61K 9/36
    A61K 31/439
    A61K 9/28
    B65D 85/00
    A61P 1/12
    A61P 1/18
    A61P 31/04
    C07D 498/22
    A61P 1/00
  • US Classification:
    424479, 540456, 514279, 424474, 206528
  • Abstract:
    The present invention relates to Rifaximin polymorphic, salt, hydrate, and amorphous forms, to their use in medicinal preparations and to therapeutic methods using them.

  • Forms Of Rifaximin And Uses Thereof

    view source
  • US Patent:
    20130066079, Mar 14, 2013
  • Filed:
    Aug 23, 2012
  • Appl. No.:
    13/593453
  • Inventors:
    Karen S. Gushurst - West Lafayette IN, US
    Donglai Yang - Annandale NJ, US
    Melanie Roe - Lafayette IN, US
    Nathan Schultheiss - Lafayette IN, US
    Petinka Vlahova - West Lafayette IN, US
    Jeffrey S. Stults - West Lafayette IN, US
    Travis L. Houston - Lafayette IN, US
  • Assignee:
    Salix Pharmaceuticals, Ltd. - Raleigh NC
  • International Classification:
    C07D 491/22
  • US Classification:
    546 40
  • Abstract:
    The present invention relates to Rifaximin polymorphic, salt, hydrate, and amorphous forms, to their use in medicinal preparations and to therapeutic methods using them.
Get Report for Donglai Yang from Milford, MA, age ~65
Control profile